These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1344 related items for PubMed ID: 18367859

  • 21. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 22. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer Zum Büschendfelde KH, Gerken G.
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [Abstract] [Full Text] [Related]

  • 23. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB, Richardson PA, Everhart JE.
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Aug; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 25. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S, Nirei K, Tamura A, Nakamura H, Matsumura H, Oshiro S, Arakawa Y, Yamagami H, Tanaka N, Moriyama M.
    Intervirology; 2008 Aug; 51(5):352-61. PubMed ID: 19127078
    [Abstract] [Full Text] [Related]

  • 26. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 27. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 28. [Hepatitis-C virus and hepatoma].
    Zala G, Havelka J, Altorfer J, Joller-Jemelka HJ, Risti B, Meier B, Schmid M, Bühler H.
    Schweiz Med Wochenschr; 1992 Feb 08; 122(6):194-7. PubMed ID: 1311125
    [Abstract] [Full Text] [Related]

  • 29. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep 08; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 30. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 08; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 Nov 08; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

  • 32. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
    Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H.
    J Viral Hepat; 2009 Jun 08; 16(6):437-43. PubMed ID: 19226331
    [Abstract] [Full Text] [Related]

  • 33. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M, Ashcavai M, Liew CT, Peters RL.
    Gastroenterology; 1979 Feb 08; 76(2):279-87. PubMed ID: 215488
    [Abstract] [Full Text] [Related]

  • 34. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC, Yuan JM, Ross RK, Govindarajan S.
    Hepatology; 1997 Jan 08; 25(1):226-8. PubMed ID: 8985295
    [Abstract] [Full Text] [Related]

  • 35. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.
    N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938
    [Abstract] [Full Text] [Related]

  • 36. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
    Tamori A, Hayashi T, Shinzaki M, Kobayashi S, Iwai S, Enomoto M, Morikawa H, Sakaguchi H, Shiomi S, Takemura S, Kubo S, Kawada N.
    J Med Virol; 2009 Jun 01; 81(6):1009-14. PubMed ID: 19382258
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M, Senota A, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, Sugai S, Yachi A.
    Hepatogastroenterology; 1994 Oct 01; 41(5):438-41. PubMed ID: 7531667
    [Abstract] [Full Text] [Related]

  • 38. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N.
    J Med Virol; 2008 Apr 01; 80(4):577-82. PubMed ID: 18297707
    [Abstract] [Full Text] [Related]

  • 39. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun 01; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 40. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 01; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.